Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: Downregulation is associated with aggressive type

Experimental Eye Research

Volumn 83, Issue 4, 2006, Pages 911-919

  Paraoan, Luminita ^a   Gray, Donna ^a   Hiscott, Paul ^a   Ebrahimi, Bahram ^a   Damato, Bertil ^a,b   Grierson, Ian ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

apoptosis; effector; monosomy 3; p53; uveal melanoma

Indexed keywords

MESSENGER RNA; PARAFFIN; PROTEIN BCL 2; PROTEIN P53;

ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; CELL TYPE; CHOROID MELANOMA; CHROMOSOME 3; CHROMOSOME 8; CILIARY BODY; COMPARATIVE STUDY; CYTOGENETICS; DISOMY; DOWN REGULATION; FROZEN SECTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MITOCHONDRION; MONOSOMY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STUDENT T TEST; UVEA MELANOMA; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BLOTTING, WESTERN; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; DOWN-REGULATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MELANOMA; MEMBRANE PROTEINS; MIDDLE AGED; MONOSOMY; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; UVEAL NEOPLASMS;

EID: 33747880450     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.04.016     Document Type: Article

References (40)

1. Aalto Y., Eriksson L., Seregard S., Larsson O., and Knuutila S. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest. Ophthalmol. Vis. Sci. 42 (2001) 313-317
2. Adachi J., Ookawa K., Kohno T., Tomizawa Y., Tsuchida S., and Yokota J. Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression. Cell Death Differ. 5 (1998) 148-155
3. Albert D.M. The ocular melanoma story. LIII Edward Jackson Memorial Lecture: Part II. Am. J. Ophthalmol. 123 (1997) 729-741
4. Attardi L.D., Reczek E.E., Cosmas C., Demicco E.G., McCurrach M.E., Lowe S.W., and Jacks T. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14 (2000) 704-718
5. Brantley Jr. M.A., and Harbour J.W. Deregulation of the Rb and p53 pathways in uveal melanoma. Am. J. Pathol. 157 (2000) 1795-1801
6. Brantley Jr. M.A., Worley L., and Harbour J.W. Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy. Am. J. Ophthalmol. 133 (2002) 242-248
7. Chana J.S., Wilson G.D., Cree I.A., Alexander R.A., Myatt N., Neale M., Foss A.J., and Hungerford J.L. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma. Br. J. Ophthalmol. 83 (1999) 110-114
8. Chao C., Saito S., Kang J., Anderson C.W., Appella E., and Xu Y. p53 Transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J. 19 (2000) 4967-4975
9. Damato B. Developments in the management of uveal melanoma. Clin. Exp. Ophthalmol. 32 (2004) 639-647
10. Damato B.E. Uveal melanoma. In: Damato B.E. (Ed). Ocular Tumours: Diagnosis and Treatment (2000), Butterworth-Heinemann, Oxford 57-93
11. Damato B.E., Paul J., and Foulds W.S. Risk factors for metastatic uveal melanoma after trans-scleral local resection. Br. J. Ophthalmol. 80 (1996) 109-116
12. Folberg R., Chen X., Boldt H.C., Pe'er J., Brown C.K., Woolson R.F., and Maniotis A.J. Microcirculation patterns other than loops and networks in choroidal and ciliary body melanomas. Ophthalmology 108 (2001) 996-1001
13. Hildebrandt T., Preiherr J., Tarbe N., Klostermann S., Van Muijen G.N., and Weidle U.H. Identification of THW, a putative new tumor suppressor gene. Anticancer Res. 20 (2000) 2801-2809
14. Hildebrandt T., van Dijk M.C., Van Muijen G.N., and Weidle U.H. Loss of heterozygosity of gene THW is frequently found in melanoma metastases. Anticancer Res. 21 (2001) 1071-1080
15. Hoglund M., Gisselsson D., Hansen G.B., White V.A., Sall T., Mitelman F., and Horsman D. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int. J. Cancer 108 (2004) 57-65
16. Ihrie R.A., and Attardi L.D. A new PERP in the lineup: linking p63 and desmosomal adhesion. Cell Cycle 4 (2005) 873-876
17. Ihrie R.A., and Attardi L.D. Perp-etrating p53-dependent apoptosis. Cell Cycle 3 (2004) 267-269
18. Ihrie R.A., Reczek E., Horner J.S., Khachatrian L., Sage J., Jacks T., and Attardi L.D. Perp is a mediator of p53-dependent apoptosis in diverse cell types. Curr. Biol. 13 (2003) 1985-1990
19. Imesch P.D., and Albert D.M. Apoptosis in uveal and skin melanoma. Invest. Ophthalmol. Vis. Sci. 38 (1997) S803
20. Khanna K.K., and Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27 (2001) 247-254
21. Kirsch D.G., and Kastan M.B. Tumor-suppressor p53: implications for tumor development and prognosis. J. Clin. Oncol. 16 (1998) 3158-3168
22. Kishore K., Ghazvini S., Char D.H., Kroll S., and Selle J. p53 Gene and cell cycling in uveal melanoma. Am. J. Ophthalmol. 121 (1996) 561-567
23. Levine A.J. p53, The cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
24. Luyten G.P., Mooy C.M., Eijkenboom W.M., Stijnen T., Hellemons L.P., Luider T.M., and de Jong P.T. No demonstrated effect of pre-enucleation irradiation on survival of patients with uveal melanoma. Am. J. Ophthalmol. 119 (1995) 786-791
25. Marques M.R., Horner J.S., Ihrie R.A., Bronson R.T., and Attardi L.D. Mice lacking the p53/p63 target gene Perp are resistant to papilloma development. Cancer Res. 65 (2005) 6551-6556
26. Mazurenko N., Attaleb M., Gritsko T., Semjonova L., Pavlova L., Sakharova O., and Kisseljov F. High resolution mapping of chromosome 6 deletions in cervical cancer. Oncol. Rep. 6 (1999) 859-863
27. Mooy C.M., Luyten G.P., de Jong P.T., Luider T.M., Stijnen T., van de H.F., van Vroonhoven C.C., and Bosman F.T. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. Am. J. Pathol. 147 (1995) 1097-1104
28. Noviello C., Courjal F., and Theillet C. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion. Clin. Cancer Res. 2 (1996) 1601-1606
29. Prives C., and Hall P.A. The p53 pathway. J. Pathol. 187 (1999) 112-126
30. Reczek E.E., Flores E.R., Tsay A.S., Attardi L.D., and Jacks T. Multiple response elements and differential p53 binding control Perp expression during apoptosis. Mol. Cancer Res. 1 (2003) 1048-1057
31. Ronen D., Schwartz D., Teitz Y., Goldfinger N., and Rotter V. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ. 7 (1996) 21-30
32. Ryan K.M., and Vousden K.H. Cancer: pinning a change on p53. Nature 419 795 (2002) 797
33. Scholes A.G., Damato B.E., Nunn J., Hiscott P., Grierson I., and Field J.K. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1008-1011
34. Singh A.D., and Topham A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 110 (2003) 962-965
35. Sisley K., Rennie I.G., Parsons M.A., Jacques R., Hammond D.W., Bell S.M., Potter A.M., and Rees R.C. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 19 (1997) 22-28
36. Sun Y., Tran B.N., Worley L.A., Delston R.B., and Harbour J.W. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1561-1564
37. Symonds H., Krall L., Remington L., Saenz R.M., Jacks T., and Van D.T. p53-Dependent apoptosis in vivo: impact of p53 inactivation on tumorigenesis. Cold Spring Harb. Symp. Quant. Biol. 59 (1994) 247-257
38. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 10 (2004) 789-799
39. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2 (2002) 594-604
40. White V.A., Chambers J.D., Courtright P.D., Chang W.Y., and Horsman D.E. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 83 (1998) 354-359